Oncotarget cover image

Oncotarget

Latest episodes

undefined
Nov 29, 2023 • 8min

Can Mechanisms of Hair Loss Shed Light on Cancer and Aging?

This podcast delves into the mechanisms of hair follicle regression and its relation to aging and cancer. Researchers discuss the role of apoptotic cells in driving cell death and propose a quantitative analysis of hair follicle length. The interaction between apoptotic cells and stem cells in hair follicle regression provides valuable insights into tissue homeostasis, cancer initiation, and the aging process.
undefined
Nov 28, 2023 • 2min

The Double-Edge Sword of CRISPR Application for In Vivo Studies

The podcast discusses the double-edged sword of CRISPR application for in vivo cancer studies, emphasizing a landmark study and the advantages and challenges it presents.
undefined
Nov 28, 2023 • 3min

Targeting Ras with Protein Engineering

The podcast discusses the challenges of targeting Ras proteins with small molecules and explores protein engineering as a potential solution. It highlights the development of the first small molecule anti-Ras drug, Sotorasib, and explores different protein engineering techniques for inhibiting Ras oncogenic mutants.
undefined
Nov 22, 2023 • 3min

Genetic Predisposition to Early Breast Cancer in Kazakh Women

Researchers studying the genetic predisposition to early breast cancer in women of Kazakh ethnicity discuss their findings on population-specific genetic markers associated with the risk of developing early-onset breast cancer and the significance of early detection.
undefined
Nov 20, 2023 • 3min

Predicting the Functions of Regulatory Genetic Variants Associated with Cancer

Researchers discuss computational methods for predicting the molecular functions of genetic variants associated with cancer and the challenges hindering our understanding. They explore the integration of genomic, epigenomic, transcriptomic, and machine learning approaches in identifying and characterizing functional genetic variants.
undefined
Nov 16, 2023 • 5min

Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer

The podcast discusses the challenges of using immunotherapy to treat pancreatic cancer, focusing on the tumor microenvironment and liver metastasis. It highlights the hypoxic and fibrotic nature of the tumor microenvironment, as well as the tolerogenic immune cells within it. The podcast also explores the differing responses to immunotherapy in primary versus metastatic pancreatic cancer, emphasizing the need for further research in this area.
undefined
Nov 15, 2023 • 2min

The Obesity Paradox: Metformin for Diabetes and Lung Cancer?

Researchers from Instituto Nacional de Cancerología discuss the relationship between obesity, diabetes, and lung cancer. Obesity induces a proinflammatory state and promotes cancer growth. The uncertainty surrounding the link is explored, along with the potential therapeutic effects of metformin on cancer cells.
undefined
Nov 13, 2023 • 2min

C/EBPβ Helps MYB Maintain the Oncogenic Program of AML Cells

Karl-Heinz Klempnauer, a researcher, discusses recent studies on the role of MYB in AML cells. MYB is a key regulator of self-renewal in AML cells, and it is also important in the development and maintenance of leukemia in humans. The podcast explores the cooperative effect of C/EBPβ and MYB in maintaining leukemic cells and the potential therapeutic applications of this knowledge.
undefined
Nov 8, 2023 • 3min

Combined Inhibition of SHP2 and Mutated RTKs Prevent Adaptive Resistance in Leukemia

In the podcast, researchers discuss potential leukemia therapies to prevent adaptive resistance. They explore the need for more potent inhibitors and combination therapies in treating leukemia.
undefined
Nov 6, 2023 • 2min

The Role of HER2 Mutant Alleles in Breast Cancer

Guests Rashi Kalra, Bora Lim, Matthew J. Ellis, and Shyam M. Kavuri discuss the role of HER2 mutant alleles in breast cancer. They explore the effects of these alleles on therapeutic response, metastatic propensity, and patient outcomes in different types of breast cancer. They also discuss the potential of the pan-HER inhibitor poziotinib as a therapeutic agent.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app